Abstract: A method and device for detecting a West Nile Virus (WNV) infection including contacting a biological sample from a subject with an anti-IgM antibody and a recombinant WNV E polypeptide and detecting whether the polypeptide substantially binds to an antibody in the sample. The invention also includes a method and device for determining whether an animal is infected with West Nile Virus (WNV), or is either not infected or is vaccinated with a WNV vaccine.
Type:
Grant
Filed:
April 28, 2004
Date of Patent:
July 11, 2006
Assignee:
IDEXX Laboratories, Inc.
Inventors:
Katherine Jean Esty, Ramaswamy Chandrashekar
Abstract: The present invention describes the identification and characterization of five human HC E1-specific monoclonal antibodies isolated from a phage display library and their use in the diagnosis, treatment, and prevention of HCV in mammals, preferably humans.
Type:
Grant
Filed:
November 30, 2001
Date of Patent:
August 2, 2005
Assignee:
The United States of America as represented by the Department of Health & Human Services
Inventors:
Darren Schofield, Suzanne U. Emerson, Robert H. Purcell, Harvey J. Alter
© 2024 Justia
